Stay updated with breaking news from Thomask Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Live webcast fireside chat on Wednesday, June 21st at 12:00 PM ETOCALA, Fla., June 14, 2023 -- AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of... | June 14, 2023
Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site now open at University of Nebraska for Phase 2 study of Ampligen® for... | June 12, 2023
– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones throughout 2023– Lead clinical program, Phase 2 locally advance... | May 15, 2023
AIM ImmunoTech Quarterly Stockholder Conference Call AIM ImmunoTech management will host a conference call and webcastto discuss the Company's Q1 2023 operational... | May 11, 2023
OCALA, Fla., May 09, 2023 -- AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and... | May 9, 2023